Breast Cancer Research and Treatment

Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients^*
pp. 1-7(7)
Authors: Hou M-F.; Tien Y-C.; Lin G-T.; Chen C-J.; Liu C-S.; Lin S-Y.; Huang T-J.

GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk
pp. 9-16(8)
Authors: Zheng W.; Wen W-Q.; Gustafson D.R.; Gross M.; Cerhan J.R.; Folsom A.R.

Delayed type hypersensitivity response to recall antigens does not accurately reflect immune competence in advanced stage breast cancer patients
pp. 17-23(7)
Authors: Schiffman K.; Rinn K.; Disis M.L.

C-myc oncogene amplification in ductal carcinoma in situ of the breast
pp. 25-31(7)
Authors: Aulmann S.; Bentz M.; Sinn H.P.

Down-regulation of the CD3- chain in sentinel node biopsies from breast cancer patients
pp. 33-40(8)
Authors: Schüle J.; Bergkvist L.; Håkansson L.; Gustafsson B.; Håkansson A.

In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines
pp. 41-46(6)
Authors: Budman D.R.; Calabro A.

Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast
pp. 47-53(7)
Authors: Zhang Z.; Yamashita H.; Toyama T.; Hara Y.; Omoto Y.; Sugiura H.; Kobayashi S.; Harada N.; Iwase H.

Overexpression of cyclin D1 enhances taxol induced mitotic death in MCF7 cells
pp. 55-63(9)
Authors: Michalides R.; Tiemessen M.; Verschoor T.; Balkenende A.; Coco-Martin J.

Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes
pp. 65-76(12)
Authors: Goodwin P.J.; Ennis M.; Pritchard K.I.; Trudeau M.E.; Koo J.; Hartwick W.; Hoffman B.; Hood N.

Delay in adjuvant radiation treatment and outcomes of breast cancer – a review
pp. 77-94(18)
Authors: Hébert-Croteau N.; Freeman C.R.; Latreille J.; Brisson J.

Instructions for Authors
pp. 95-99(5)
Author: Lippman M.D. M.E.